Literature DB >> 22425745

Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.

Qi Zhang1, Rui Pu, Yan Du, Yifang Han, Tong Su, Hongyang Wang, Guangwen Cao.   

Abstract

Non-coding RNA (ncRNA), a class of RNAs that do not code protein but have regulatory functions, can regulate gene expression and replication of hepatitis B virus or hepatitis C virus and play an important role in the virus-host interaction and the development of hepatocellular carcinoma (HCC). Deregulated ncRNAs in surgically removed hepatic tissues and circulation can be prognostic and diagnostic markers, respectively. ncRNAs functioning as either tumor suppressors or oncogenes can be therapeutic options. Here, we summarize the deregulated ncRNAs associated with the infections and HCC and focus on their roles on early diagnosis, prognosis prediction and therapeutic option of HCC.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425745     DOI: 10.1016/j.canlet.2012.03.011

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

1.  Predictive prognostic role of miR-181a with discrepancy in the liver and serum of genotype 4 hepatitis C virus patients.

Authors:  Dalia Sherif Elhelw; Radwa Yehia Mekky; Nada El-Ekiaby; Rasha Ahmed; Mohammad Ahmed Mohey Eldin; Mohammad El-Sayed; Mahmoud Mohammad Abouelkhair; Ayman Salah; Abdel Rahman Zekri; Gamal Esmat; Ahmed Ihab Abdelaziz
Journal:  Biomed Rep       Date:  2014-08-13

Review 2.  Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.

Authors:  Jason Lamontagne; Laura F Steel; Michael J Bouchard
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 3.  MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Mohammad Reza Mahmoudian-Sani; Samira Asgharzade; Arash Alghasi; Ali Saeedi-Boroujeni; Seyed Jafar Adnani Sadati; Mohammad Taghi Moradi
Journal:  J Gastrointest Oncol       Date:  2019-08

4.  Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs.

Authors:  Yu Zhou; Li Sun; Xu Wang; Li Zhou; Jieliang Li; Manqing Liu; Fang Wang; Jinsong Peng; Xi'en Gui; Huaqing Zhao; Nancy Reichenbach; Dunjin Zhou; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-09       Impact factor: 4.147

5.  A Platform for Discovery and Quantification of Modified Ribonucleosides in RNA: Application to Stress-Induced Reprogramming of tRNA Modifications.

Authors:  Weiling Maggie Cai; Yok Hian Chionh; Fabian Hia; Chen Gu; Stefanie Kellner; Megan E McBee; Chee Sheng Ng; Yan Ling Joy Pang; Erin G Prestwich; Kok Seong Lim; I Ramesh Babu; Thomas J Begley; Peter C Dedon
Journal:  Methods Enzymol       Date:  2015-07-17       Impact factor: 1.600

6.  Challenges of incorporating gene expression data to predict HCC prognosis in the age of systems biology.

Authors:  Yan Du; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

7.  Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

Authors:  Yan Du; Xue Han; Rui Pu; Jiaxin Xie; Yuwei Zhang; Guangwen Cao
Journal:  Front Med       Date:  2014-04-21       Impact factor: 4.592

Review 8.  Diagnostic and Prognostic Value of MicroRNA in Viral Diseases.

Authors:  Eeva Auvinen
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

Review 9.  Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.

Authors:  Weihong Hou; Herbert L Bonkovsky
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

10.  Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.

Authors:  Shu-Hao Hsu; Bo Yu; Xinmei Wang; Yuanzhi Lu; Carl R Schmidt; Robert J Lee; L James Lee; Samson T Jacob; Kalpana Ghoshal
Journal:  Nanomedicine       Date:  2013-05-30       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.